Kepos Capital’s Halozyme HALO Stock Holding History

Kepos Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-75,329	Closed	-$1.29M	–	351
2019 Q2	$1.29M	Hold	75,329	–	–	0.13%	145
2019 Q1	$1.21M	Buy	+75,329	New	+$1.22M	0.09%	199

Other funds holding HALO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Kepos Capital's HALO Position: Q3 2019 in Review

Kepos Capital sold out of Halozyme (HALO) in Q3 2019, closing a stake of 75,329 shares — an estimated $1.29M sold.

Kepos Capital first reported a position in HALO in Q1 2019 and held it in 2 quarters. The position peaked at $1.29M in Q2 2019. 210 funds tracked by Wall St. Rank hold HALO as of Q3 2019.

Kepos Capital reported no remaining Halozyme position as of Q3 2019 after selling out during the quarter.
Kepos Capital sold 75,329 Halozyme shares in Q3 2019, an estimated $1.29M.
Kepos Capital first reported a position in Halozyme in Q1 2019 and held it in 2 quarters.
Kepos Capital's Halozyme position peaked at $1.29M in Q2 2019.
210 funds tracked by Wall St. Rank held Halozyme as of Q3 2019.

Based on Kepos Capital's 13F filing for Q3 2019, filed 13 Nov 2019.